National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Childhood Craniopharyngioma Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 08/03/2009



Purpose of This PDQ Summary






General Information






Background Information About Childhood Craniopharyngioma






Histopathologic Classification of Childhood Craniopharyngioma






Diagnostic Evaluation of Childhood Craniopharyngioma






Stage Information






Treatment Options for Newly Diagnosed Childhood Craniopharyngioma







Treatment Options for Recurrent Childhood Craniopharyngioma






Late Effects in Patients Treated for Childhood Craniopharyngioma






Get More Information From NCI






Changes to This Summary (08/03/2009)






More Information



Page Options
Print This Page  Print This Page
Print This Document  Print Entire Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Office of Biorepositories and Biospecimen Research

The Nation's Investment in Cancer Research FY 2010

Report to Nation Finds Declines in Cancer Incidence, Death Rates
Treatment Options for Recurrent Childhood Craniopharyngioma

Recurrence of craniopharyngioma occurs with all modalities of primary therapy. Management is determined in large part by prior therapy. Repeat attempts at gross total resection are difficult, and complications are more frequent than with initial surgery.[1] External-beam radiation therapy is an option if this has not been previously employed. Cystic recurrences may be treated with intracavitary instillation of radioactive 32P, or bleomycin,[2] and a reservoir may be placed to permit intermittent outpatient aspiration. Chemotherapy is generally not utilized.

References

  1. Wisoff JH: Surgical management of recurrent craniopharyngiomas. Pediatr Neurosurg 21 (Suppl 1): 108-13, 1994.  [PUBMED Abstract]

  2. Takahashi H, Nakazawa S, Shimura T: Evaluation of postoperative intratumoral injection of bleomycin for craniopharyngioma in children. J Neurosurg 62 (1): 120-7, 1985.  [PUBMED Abstract]

Back to TopBack to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov